A
WST icon

AlphaQuest’s West Pharmaceutical WST Stock Holding History

AlphaQuest’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-988
Closed -$272K – 2114
2025
Q4 		$272K Sell
988
-192
-16% -$52.5K 0.02% 1269
2025
Q3 		$310K Buy
1,180
+14
+1% +$3.4K 0.02% 1135
2025
Q2 		$255K Buy
1,166
+372
+47% +$79.5K 0.03% 982
2025
Q1 		$178K Buy
794
+745
+1,520% +$205K 0.02% 1045
2024
Q4 		$16.1K Buy
+49
New +$15.4K ﹤0.01% 1440
2024
Q3 		– Sell
-172
Closed -$56.7K – 2004
2024
Q2 		$56.7K Buy
172
+169
+5,633% +$59.7K 0.01% 1052
2024
Q1 		$1.19K Sell
3
-1,544
-100% -$571K ﹤0.01% 1314
2023
Q4 		$545K Buy
+1,547
New +$547K 0.12% 316

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaQuest's WST Position: Q1 2026 in Review

AlphaQuest sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 988 shares — an estimated $272K sold.

AlphaQuest first reported a position in WST in Q4 2023 and held it in 8 quarters. The position peaked at $545K in Q4 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • AlphaQuest reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 988 West Pharmaceutical shares in Q1 2026, an estimated $272K.
  • AlphaQuest first reported a position in West Pharmaceutical in Q4 2023 and held it in 8 quarters.
  • AlphaQuest's West Pharmaceutical position peaked at $545K in Q4 2023.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.